Clenbuterol and the horse revisited

Veterinary Journal

Volumn 182, Issue 3, 2009, Pages 384-391

  Kearns, Charles F ^a   McKeever, Kenneth H ^a  

^a The State University of New Jersey   (United States)

Author keywords

2 agonist; Clenbuterol; Equine; Horse

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CLENBUTEROL; DEXAMETHASONE;

BRONCHOSPASM; CHRONIC DRUG ADMINISTRATION; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG EFFECT; ENDOCRINE SYSTEM; GENITAL SYSTEM; HEART DISEASE; HORSE; IMMUNE SYSTEM; MUSCLE DISEASE; NONHUMAN; RESPIRATORY TRACT DISEASE; REVIEW; SHORT COURSE THERAPY; SYRUP;

ADRENERGIC BETA-AGONISTS; ANIMALS; BRONCHIAL DISEASES; CLENBUTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART DISEASES; HORSE DISEASES; HORSES; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PHYSICAL CONDITIONING, ANIMAL;

EQUIDAE;

EID: 71549165146     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.08.021     Document Type: Review

References (87)

1. Abraham G., Brodde O.E., and Ungemach F.R. Regulation of equine lymphocyte beta-adrenoceptors under the influence of clenbuterol and dexamethasone. Equine Veterinary Journal 34 (2002) 587-593
2. Baker P.K., Dalrymple R.H., Ingle D.L., and Ricks C.A. Use of a ß-adrenergic agonist to alter muscle and fat deposition in lambs. Journal of Animal Science 59 (1984) 1256-1261
3. Bakker A.J., Head S.I., Wareham A.C., and Stephenson D.G. Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers. American Journal of Physiology 274 (1998) C1718-C1726
4. Barmbilla G., Cenci T., Franconi F., Galarini R., Macri A., Rondoni F., Strozzi M., and Loizzo A. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicology Letters 114 (2000) 47-53
5. Beekley M.D., Ideaus J.M., Brechue W.F., Kearns C.F., and McKeever K.H. Chronic clenbuterol administration alters myosin heavy chain composition in Standardbred horses. The Veterinary Journal 165 (2003) 234-239
6. Benson D.W., Foley-Nelson T., Chance W.T., Zhang F., James J.J., and Fischer J.E. Decreased myofibrillar protein breakdown following treatment with clenbuterol. The Journal of Surgical Research 50 (1991) 1-5
7. Biolatti B., Castagnaro M., Bollo E., Appino S., and Re G. Genital lesions following long-term administration of clenbuterol in female pigs. Veterinary Pathology 31 (1994) 82-92
8. Blanco A., Agüera E., Flores R., Artacho-Pérula E., and Monterde J.G. Morphological and quantitative study of the Leydig cells of pigs fed with anabolic doses of clenbuterol. Research in Veterinary Science 71 (2001) 85-91
9. Blanco A., Artacho-Pérula E., Flores-Acuña R., Agüera E., and Monterde J.G. Quantitative modification of the testicular structure in pigs fed with anabolic doses of clenbuterol. Veterinary Research 33 (2002) 47-53
10. Blanco A., Flores-Acuña F., Roldán-Villalobos R., and Monterde J.G. Testicular damage from anabolic treatments with the beta(2)-adrenergic agonist clenbuterol in pigs: a light and electron microscope study. The Veterinary Journal 163 (2002) 292-298
11. Bloomfield S.A., Girten B.E., and Weisbrode S.E. Effects of vigorous exercise training and beta-agonist administration on bone response to hindlimb suspension. Journal of Applied Physiology 83 (1997) 172-178
12. Bostedt H. The use of a beta 2-mimetic agent (clenbuterol) in equine pregnancy disorders and obstetrics. Tierarztliche Praxis 16 (1988) 57-59
13. Burniston J.G., Ng Y., Clark W.A., Colyer J., Tan L.B., and Goldspink D.F. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. Journal of Applied Physiology 93 (2002) 1824-1832
14. Burniston J.G., Ellison G.M., Clark W.A., Goldspink D.F., and Tan L.B. Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others. Cardiovascular Toxicology 5 (2005) 355-364
15. Burniston J.G., Tan L.B., and Goldspink D.F. Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats. Experimental Physiology 91 (2006) 1041-1049
16. Burniston J.G., Clark W.A., Tan L.B., and Goldspink D.F. Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle and Nerve 33 (2006) 655-663
17. Burniston J.G., McLean L., Beynon R.J., and Goldspink D.F. Anabolic effects of a non-myotoxic dose of the beta2-adrenergic receptor agonist clenbuterol on rat plantaris muscle. Muscle and Nerve 35 (2007) 217-223
18. Castle A., Yaspelkis III B.B., Kuo C.H., and Ivy J.L. Attenuation of insulin resistance by chronic beta2-adrenergic agonist treatment possible muscle specific contributions. Life Sciences 69 (2001) 599-611
19. Cavalie H., Lac G., Lebecque P., Chanteranne B., Davicco M.J., and Barlet J.P. Influence of clenbuterol on bone metabolism in exercised or sedentary rats. Journal of Applied Physiology 93 (2002) 2034-2037
20. Claeys M.C., Mulvaney D.R., McCarthy F.D., Gore M.T., Marple D.N., and Sartin J.L. Skeletal muscle protein synthesis and growth hormone secretion in young lambs treated with clenbuterol. Journal of Animal Science 67 (1989) 2245-2254
21. Convertino V.A., Keil L.C., and Greenleaf J.E. Plasma volume, renin, and vasopressin responses to graded exercise after training. Journal of Applied Physiology 54 (1983) 508-514
22. Cornelisse C.J., Schott H.C., Olivier N.B., Mullaney T.P., Koller A., Wilson D.V., and Derksen F.J. Concentration of cardiac troponin I in a horse with a ruptured aortic regurgitation jet lesion and ventricular tachycardia. Journal of the American Veterinary Medical Association 217 (2000) 231-235
23. Criswell D.S., Powers S.K., and Herb R.A. Clenbuterol-induced fiber type transition in the soleus of adult rats. European Journal of Applied Physiology 74 (1996) 391-396
24. Cubria J.C., Reguera R., Balana-Fouce R., Ordonez C., and Ordonez D. Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse. The Journal of Pharmacy and Pharmacology 50 (1998) 91-96
25. Cubría J.C., Ordóñez C., Reguera R.M., Tekwani B.L., Balaña-Fouce R., and Ordóñez D. Early alterations of polyamine metabolism induced after acute administration of clenbuterol in mouse heart. Life Science 64 (1999) 1739-1752
26. Dalrymple R.H., Baker P.K., Gengher P.K., Ingle D.L., Pensack J.M., and Ricks C.A. A repartitioning agent to improve performance and carcass composition in broilers. Poultry Science 63 (1984) 2376-2383
27. Delbeke F.T., Desmet N., and Debackere M. The abuse of doping agents in competing bodybuilders in Flanders. International Journal of Sports Medicine 16 (1995) 66-70
28. Dodd S.L., Powers S.K., Vrabis I.S., Criswell D., Stetson S., and Hussain R. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle. Medicine and Science in Sports and Exercise 28 (1996) 669-676
29. Duncan N.D., Williams D.A., and Lynch G.S. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats. Clinical Science 98 (2000) 339-347
30. Emery P.W., Rothwell N.J., Stock M.J., and Winter P.D. Chronic effects of b2-adrenergic agonist on body composition and protein synthesis in the rat. Bioscience Reports 4 (1984) 83-91
31. Erichsen D.F., Aviad A.D., Shultz R.H., and Kennedy T.J. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD). Equine Veterinary Journal 26 (1994) 331-336
32. Gastal M.O., Gastal E.L., Torres C.A., and Ginther O.J. Effect of oxytocin, prostaglandin F2 alpha, and clenbuterol on uterine dynamics in mares. Theriogenology 50 (1998) 521-534
33. Guldner N.W., Klapproth P., Grossherr M., Stephan M., Rumpel E., Noel R., and Sievers H.H. Clenbuterol-supported dynamic training of skeletal muscle ventricles against systemic load: a key for powerful circulatory assist?. Circulation 101 (2000) 2213-2219
34. Hahnau S., and Julicher B. Evaluation of commercially available ELISA test kits for the detection of clenbuterol and other β2-agonist. Food Additives and Contaminants 13 (1996) 259-274
35. Illera J.C., Silvan G., Blass A., Martinez M.M., and Illera M. The effect of clenbuterol on adrenal function in rats. Analyst 123 (1998) 2521-2524
36. Illera J.C., Pena L., Martinez-Mateos M.M., Camacho L., Blass A., Garcia-Partida P., Illera M.J., and Silvan G. The effect of long term exposure to combinations of growth promoters in Long Evans rats: part 2. Adrenal morphology (histopathology and immunochemical studies). Analytica Chimica Acta 586 (2007) 252-258
37. Ingalls C.P., Barnes W.S., and Smith S.B. Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content. Journal of Applied Physiology 80 (1996) 795-801
38. Kallings P., Ingvast-Larsson C., Persson S., Appelgren L.-E., Forster H.J., and Rominger K.L. Clenbuterol plasma concentration after repeated oral administration and its effects on cardio-respiratory and blood lactate responses to exercise in healthy Standardbred horses. Journal of Veterinary Pharmacology and Therapeutics 14 (1991) 243-249
39. Kearns C.F., and McKeever K.H. Clenbuterol diminishes aerobic performance in horses. Medicine and Science in Sports and Exercise 34 (2002) 1976-1985
40. Kearns C.F., McKeever K.H., Malinowski K., Struck M.B., and Abe T. Chronic administration of therapeutic levels of clenbuterol acts as a repartitioning agent. Journal of Applied Physiology 91 (2001) 2064-2070
41. Kearns C.F., McKeever K.H., and Abe T. Overview of horse body composition and muscle architecture - implications for performance. The Veterinary Journal 64 (2002) 224-234
42. Kearns C.F., McKeever K.H., Roegner V., Brady S.M., and Malinowski K. Adiponectin and leptin are related to fat mass in horses. The Veterinary Journal 172 (2006) 460-465
43. Kearns C.F., McKeever K.H., and Malinowski K. Changes in adiponectin, leptin, and fat mass after clenbuterol treatment in horses. Medicine and Science in Sports and Exercise 38 (2006) 262-267
44. Kellenberger S., Muller K., Richener H., and Bilbe G. Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors. Bone 22 (1998) 471-478
45. Kiely, R.G., 1985. Mucociliary transport rate in the horse and its modification with various pharmacologic agents. In: Proceedings of the American College of Veterinary Internal Medicine, San Diego, Calif, USA, p. 126.
46. Kiely, R.G., Jenkins, W.L., 1985. The effect of clenbuterol chloride on the mucociliary transport rate in horses with a clinical diagnosis of chronic obstructive pulmonary disease (COPD). In: Proceedings of the American College of Veterinary Internal Medicine, San Diego, Calif, USA, p. 146.
47. Kitaura T., Tsunekawa N., and Kramer W.J. Inhibited longitudinal growth of bones in young male rats by clenbuterol. Medicine and Science in Sports and Exercise 34 (2002) 267-273
48. Kuiper H.A., Noordam M.Y., van Dooren-Flipsen M.M.H., Schilt R., and Roos A.H. Illegal use of β-adrenergic agonist: European community. Journal of Animal Science 76 (1998) 195-207
49. Laan T.T., Bull S., Pirie R.S., and Fink-Gremmels J. The anti-inflammatory effects of IV administered clenbuterol in horses with recurrent airway obstruction. The Veterinary Journal 171 (2006) 429-437
50. 2-agonist administration and exercise on contractile activation of skeletal muscle fibers. Journal of Applied Physiology 81 (1996) 1610-1618
51. Lynch G.S., Hinkle R.T., and Faulkner J.A. Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles. Clinical and Experimental Pharmacology and Physiology 26 (1999) 117-120
52. MacLennan P.A., and Edwards R.H.T. Effects of clenbuterol and propranolol on muscle mass: evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy. Biochemical Journal 264 (1989) 573-579
53. Malinowski K., Kearns C.F., Guirnalda P.D., Roegner V., and McKeever K.H. Effect of chronic clenbuterol administration and exercise training on immune function in horses. Journal of Animal Science 82 (2004) 3500-3507
54. Maltin C.A., Delday M.I., Hay S.M., Smith F.G., Lobley G.E., and Reeds P.J. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Bioscience Reports 7 (1987) 143-149
55. Maltin C.A., Hay S.M., Delday M.I., Lobley G.E., and Reeds P.J. The action of b-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscle. Biochemical Journal 261 (1989) 965-971
56. McKeever KH. Effects of sympathomimetic and sympatholytic drugs on exercise performance. Veterinary Clinics of North America: Equine Practice 9 (1993) 635-647
57. McKeever K.H., and Gordon M.E. Endocrine alterations in the equine athlete. In: Hinchcliff K.W., Kaneps A., and Geor G. (Eds). Equine Exercise Physiology (2007), Elsevier, Philadelphia 278-304
58. McManus C.J., and Fitzgerald B.P. Effect of daily clenbuterol and exogenous melatonin treatment on body fat, serum leptin and the expression of seasonal anestrus in the mare. Animal Reproduction Science 76 (2003) 217-230
59. Menard L. Tocolytic drugs for use in veterinary obstetrics. Canadian Veterinary Journal 25 (1984) 389-393
60. Nairne A.C., and Picciotto M.R. Calcium/calmodulin-dependent protein kinases. Seminars in Cancer Biology 5 (1994) 295-303
61. Nikolakopoulos E., and Watson E.D. Uterine contractility is necessary for the clearance of intrauterine fluid but not bacteria after bacterial infusion in the mare. Theriogenology 52 (1999) 413-423
62. 2+ sensitivity of permeabilized fast muscle fibers from exercise trained or untrained horses. Journal of Muscle Research and Cell Motility 24 (2003) 471-476
63. Re G., Badino P., Novelli A., and Girardi C. Down-regulation of beta-adrenergic receptors and up-regulation of estrogen and progesterone receptors induced in the reproductive system of female veal calves by dietary clenbuterol. American Journal of Veterinary Research 56 (1995) 1493-1497
64. Re G., Badino P., Novelli A., Canese M.G., and Girardi C. Identification of beta-adrenoceptor subtypes in bovine ovarian and myometrial cell membranes. British Veterinary Journal 151 (1995) 567-578
65. Reeds P.J., Hay S.M., Dorwood P.M., and Palmer R. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. British Journal of Nutrition 56 (1986) 249-258
66. Reeds P.J., Hay S.M., Dorward P.M., and Palmer R.M. The effect of β-agonists and antagonists on muscle growth and body composition of young rats (Rattus sp.). Comparative Biochemistry and Physiology 89C (1988) 337-341
67. Ricks C.A., Dalrymple R.H., Baker P.K., and Ingle D.L. Use of a β-agonist to alter fat and muscle deposition in steers. Journal of Animal Science 59 (1984) 1247-1255
68. Rose R.J., and Evans D.L. Cardiorespiratory effects of clenbuterol in fit Thoroughbred horses during a maximal exercise test. In: Gillespie J.R., and Robinson N.E. (Eds). Equine Exercise Physiology 2. ICEEP Publications, San Diego (1984), Calif, USA 117-131
69. Rose R.J., Allen J.R., and Brock K.A. Effects of clenbuterol hydrochloride on certain respiratory and cardiovascular parameters in horses performing treadmill exercise. Research in Veterinary Science 35 (1983) 301-305
70. Sasse H.H., and Hajer R. NAB 365, a beta 2 receptor sympathomimetic agent: clinical experience in horses with lung disease. Journal of Veterinary Pharmacology and Therapeutics 1 (1978) 241-243
71. Sibley D.R., and Lefkowitz R.J. Beta-adrenergic receptor-coupled adenylate cyclase. Biochemical mechanisms of regulation. Molecular Neurobiology 1 (1987) 121-154
72. Sibley D.R., Benovic J.L., Caron M.G., and Lefkowitz R.J. Molecular mechanisms of beta-adrenergic receptor desensitization. Advances in Experimental Medical Biology 221 (1987) 253-273
73. Sleeper M., McKeever K.H., and Kearns C.F. Chronic clenbuterol administration negatively alters cardiac function in the Standardbred mare. Medicine and Science in Sports and Exercise 34 (2002) 643-650
74. Slocombe R.F., Covelli G., and Bayly W.M. Respiratory mechanics of horses during stepwise treadmill exercise tests, and the effect of clenbuterol pretreatment on them. Australian Veterinary Journal 69 (1992) 221-225
75. Smith D.J. Total radioactive residues and clenbuterol residues in edible tissues, and the stereochemical composition of clenbuterol in livers of broilers after exposure to three levels of dietary [14C]clenbuterol HCl and three preslaughter withdrawal periods. Journal of Animal Science 76 (1998) 3043-3053
76. Smith D.R., Leach D.H., and Bell R.J. Phalangeal and navicular bone hypoplasia and hoof malformation in the hind limbs of a foal. Canadian Veterinary Journal 27 (1986) 28-34
77. Soma L.R., Uboh C.E., Guan F., Luo Y., Teleis D., Runbo L., Birks E.K., Tsang D.S., and Habecker P. Tissue distribution of clenbuterol in the horse. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 91-98
78. Soma L.R., Uboh C.E., Guan F., Moate P., Luo Y., Teleis D., Li R., Birks E.K., Rudy J.A., and Tsang D.S. Pharmacokinetics and disposition of clenbuterol in the horse. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 71-77
79. Suzuki J., Gao M., and Xie Z. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats. Acta Physiologica Scandinavica 161 (1997) 317-326
80. Togari A., Arai M., Mizutani S., Mizutani S., Koshihara Y., and Nagatsu T. Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neuroscience Letters 233 (1997) 125-128
81. Torgan C.E., Etgen Jr. G.J., Brozinick Jr. J.T., Wilcox R.E., and Ivy J.L. Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle. Journal of Applied Physiology 75 (1993) 1471-1476
82. Torgan C.E., Etgen Jr. G.J., Kang H.Y., and Ivy J.L. Fiber type-specific effects of clenbuterol and exercise training on insulin-resistant muscle. Journal of Applied Physiology 79 (1995) 163-167
83. United States Food and Drug Administration, 1998. Freedom of Information Summary of NADA 140-973. .
84. van den Hoven R., Duvigneau J.C., Hartl R.T., and Gemeiner M. Clenbuterol affects the expression of messenger RNA for interleukin 10 in peripheral leukocytes from horses challenged intrabronchially with lipopolysaccharides. Veterinary Research Communications 30 (2006) 921-928
85. Zeman R.J., Ludemann R., Easton T.G., and Etlinger J.D. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a β2-receptor agonist. American Journal of Physiology 254 (1988) E726-E732
86. Zeman R.J., Hirschman A., Hirschman M.L., Guo G., and Etlinger J.D. Clenbuterol, a beta 2-receptor agonist, reduces net bone loss in denervated hindlimbs. American Journal of Physiology 261 (1991) E285-E289
87. Zsolnai B., Varga B., Horváth E., and Stark E. Effects of beta 2-adrenergic stimulants on the progesterone and oestradiol-17 beta serum levels in pseudopregnant rats. Acta Physiologica Hungaria 77 (1991) 7-11